Literature DB >> 25339392

Unbiased species-level identification of clinical isolates of coagulase-negative Staphylococci: does it change the perspective on Staphylococcus lugdunensis?

Wael F Elamin1, David Ball2, Michael Millar2.   

Abstract

Unbiased species-level identification of coagulase-negative staphylococci (CoNS) using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) identified Staphylococcus lugdunensis to be a more commonly isolated CoNS in our laboratory than previously observed. It has also highlighted the possibility of vertical transmission.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25339392      PMCID： PMC4290939          DOI： 10.1128/JCM.02932-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection.

Authors:  T E Herchline; L W Ayers
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology.

Authors:  Robin Patel
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

3.  Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors.

Authors:  D W Lambe; K P Ferguson; J L Keplinger; C G Gemmell; J H Kalbfleisch
Journal:  Can J Microbiol       Date:  1990-07       Impact factor: 2.419

Review 4.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body.

Authors:  K P Ferguson; D W Lambe; J L Keplinger; J H Kalbfleisch
Journal:  Can J Microbiol       Date:  1991-09       Impact factor: 2.419

6.  Group B streptococcal carriage and disease: a 6-year prospective study.

Authors:  H C Dillon; S Khare; B M Gray
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

7.  Microbiological characteristics, presumptive identification, and antibiotic susceptibilities of Staphylococcus lugdunensis.

Authors:  Thean Yen Tan; Siew Yong Ng; Jie He
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

8.  Clinical and epidemiological significance of species identification of coagulase-negative staphylococci in a microbiological laboratory.

Authors:  I Oren; D Merzbach
Journal:  Isr J Med Sci       Date:  1990-03

9.  Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community.

Authors:  Sidsel Böcher; Birgitte Tønning; Robert L Skov; Jørgen Prag
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

10.  Identification of a variety of Staphylococcus species by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Damien Dubois; David Leyssene; Jean Paul Chacornac; Markus Kostrzewa; Pierre Olivier Schmit; Régine Talon; Richard Bonnet; Julien Delmas
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948
View more
  6 in total

1.  Implementation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Routine Clinical Laboratories Improves Identification of Coagulase-Negative Staphylococci and Reveals the Pathogenic Role of Staphylococcus lugdunensis.

Authors:  Xavier Argemi; Philippe Riegel; Thierry Lavigne; Nicolas Lefebvre; Nicolas Grandpré; Yves Hansmann; Benoit Jaulhac; Gilles Prévost; Frédéric Schramm
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  Epidemiology, Clinical Characteristics, and Antimicrobial Susceptibility Profiles of Human Clinical Isolates of Staphylococcus intermedius Group.

Authors:  Melanie L Yarbrough; William Lainhart; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

3.  Evaluation of Oxacillin and Cefoxitin Disk Diffusion and MIC Breakpoints Established by the Clinical and Laboratory Standards Institute for Detection of mecA-Mediated Oxacillin Resistance in Staphylococcus schleiferi.

Authors:  H K Huse; S A Miller; S Chandrasekaran; J A Hindler; S D Lawhon; D A Bemis; L F Westblade; R M Humphries
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

Review 4.  Is Staphylococcus lugdunensis Significant in Clinical Samples?

Authors:  Xavier Argemi; Yves Hansmann; Philippe Riegel; Gilles Prévost
Journal:  J Clin Microbiol       Date:  2017-08-23       Impact factor: 5.948

Review 5.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

Review 6.  Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential.

Authors:  Simon Heilbronner; Timothy J Foster
Journal:  Clin Microbiol Rev       Date:  2020-12-23       Impact factor: 26.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.